| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |